@Christian_CCRS@HappyQuailPress@WorldSIOP These things happen but this story is a bit different as the drug was also deemed ineffective and toxic. Probably not a great candidate for DIPG.
13 years ago this month, my son was diagnosed with brain cancer. I promised him that I would do everything I could to help kids with #ChildhoodCancer. It’s the only thing he asked us to do. Not to help him, but to help others. I would be grateful for a follow or a RT to spread awareness and honor his journey. 🙏🏻
The @gatesfoundation stumbled on a big financial win with Anacor Pharmaceuticals, thanks to a soaring share price as the company’s drugs made progress, and the foundation sold 99% of its stake for $86.7 million in November 2015, 17 times its initial 2013 investment of $5 million
On International #childhoodancer day a glimmer of hope in the quest to cure the deadliest cancer in children, by using a well-known drug in an innovative way. This is why at aPODD we believe in drug re-purposing. #childhoodcancerawareness
https://t.co/YkRVI8UxLC
@mattmight@bertrandmight We are so sorry to hear this. We still remember your wonderful presentation in Cambridge UK, some years ago. We are sending our heartfelt condolescences. I am sure you and Bertand will remain inspiration and model for millions of rare disease patients across the world.
Childhood Cancers awareness we are sharing our #charitypartner@aPODDfoundation news! Introducing Andrew Westwood, Andrew is a Trustee and also a parent who’s family have experienced first-hand childhood cancer and now wants to help others.
https://t.co/M5LVoUEmGy
#CCAM
September is Childhood Cancer Awareness Month
Find out about the brilliant work our charity partners @aPODDfoundation are doing to find better and kinder treatments for children with cancer as quickly as possible.
https://t.co/aWnG2rAegE
#childhoodcancerawarenessmonth
Delighted to be on Twitter! 😊
ACCELERATE aims to strengthen int'l cooperation (academia, parent groups, biopharma companies, regulatory bodies, HTAs) to improve global devpt of new paediatric oncology drugs.
Please follow us & engage in the discussions!
#ACCELERATEplatform
Our latest #blog looks at our recent #RareWorkshop - Diving in to Drug Repurposing. If your patient groups wants to get involved in this area of research check it out. Our video of Evie Mengou of @aPODDfoundation will hopefully provide some inspiration!
https://t.co/J9tdYR9zly
Q. How can #AI tech help speed up the discovery and development of repurposed #raredisease treatments?
A. We’re about to find out as Dr Tony Hall (CMO) takes to the stage @findacure_fdn’s #DrugRepo conference!
We're in London today @findacure_fdn's Drug Repurposing for Rare Diseases event! Will we see you here?
Join us on stand or listen to our CMO Anthony Hall's talk (14:20) to discover how #AI and #ML tech is speeding up #drugrepo for #rarediseases.
Children around the world do not have equal access to cancer treatment and many children are living in unnecessary pain.
At aPODD we are focused on using #drugrepurposing to identify new treatments.
https://t.co/fsSgkp8SWT
#CUREALL#NOMOREBORDERS#childhoodcancer
Today we support International Childhood Cancer Day.
We understand that if we are to accelerate finding new treatments for children with cancer then we must collaborate internationally.
Visit our website https://t.co/cK3yEKcrR3
#CUREALL#NOMOREBORDERS#childhoodcancer
aPODD Trustee Evgenia Mengou teams up with Findacure CEO Rick Thompson to discuss drug repurposing and they also share highlights from the 'Diving into drug repurposing' workshop held in November 2019.
#drugrepurposing#raredisease#childhoodcancer
https://t.co/pjV4wi9ZpB